Cargando…
Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270564/ https://www.ncbi.nlm.nih.gov/pubmed/34242389 http://dx.doi.org/10.1182/bloodadvances.2021005193 |
| _version_ | 1783720821095661568 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8270564 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82705642021-07-20 Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. Blood Adv Erratum American Society of Hematology 2021-07-09 /pmc/articles/PMC8270564/ /pubmed/34242389 http://dx.doi.org/10.1182/bloodadvances.2021005193 Text en © 2021 by The American Society of Hematology |
| spellingShingle | Erratum Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title | Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title_full | Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title_fullStr | Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title_full_unstemmed | Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title_short | Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190. |
| title_sort | zhou z, nath r, cerny j, et al. reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a cibmtr report. blood adv. 2020;4(13):3180-3190. |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270564/ https://www.ncbi.nlm.nih.gov/pubmed/34242389 http://dx.doi.org/10.1182/bloodadvances.2021005193 |